Search - tctmd.com

Displaying 41 - 58 of 58

Presentation TCT 2013

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye, Mark Webster, James Stewart, Alexandre Abizaid, RICARDO COSTA, Jose Costa Jr, John Yan, vinayak bhat, lynn morrison, Sara Toyloy, John Ormiston

January 31, 2013

Presentation TCT 2013

Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavo...

Presenter: Stefan Verheye, Christophe Dubois, Karl-Eugen Hauptmann, John Ormiston, James Stewart, Joachim Schofer, Karl Stangl, Bernhard Witzenbichler, Emanuele Barbato, Peter Fitzgerald, Hiromasa Otake, Patrick Serruys

January 31, 2013

Presentation TCT 2013

A Novel Catheter-Based Mitral Valve Bio-Prosthesis Short Term Pre-Clinical Results

Presenter: Shmuel Banai, Marc Jolicoeur, Jean-Fran?ois Tanguay, Stefan Verheye, Christopher White, Elazer Edelman

January 31, 2013

News Daily News

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

December 17, 2012

News Daily News

APPOSITION II Publicado: El Stent Auto Expandible Funciona Bien en Pacientes STEMI

December 17, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

Presentation TCT 2012

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: Biosensors Program Update

Presenter: Stefan Verheye

October 22, 2012

Presentation TCT 2012

Dedicated Bifurcation Stents: STENTYS Program Update

Presenter: Stefan Verheye

October 22, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

News Industry News

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

May 15, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

Presentation TCT 2012

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Presenter: John A. McPherson, Akiko Maehara, Giora Weisz, Gary S. Mintz, Ecaterina Cristea, Roxana Mehran, Michael Foster, Stefan Verheye, Leroy Rabbani, Ke Xu, Martin Fahy, Alexandra J. Lansky, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

News Industry News

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

November 10, 2011

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Industry News

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

November 02, 2011

News Industry News

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

May 19, 2011

Advertisement

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Multi Center, Prospective, Randomized, Single Blind, Consecutive Enrollment Evaluation Of Elixir DESyneTM Novolimus-Eluting Coronary Stent System With Durable Polymer To Endeavo...

A Novel Catheter-Based Mitral Valve Bio-Prosthesis Short Term Pre-Clinical Results

APPOSITION II Published: Self-Expanding Stent Performs Well in STEMI Patients

APPOSITION II Publicado: El Stent Auto Expandible Funciona Bien en Pacientes STEMI

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

TCT-563: Multicenter First-in-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Dedicated Bifurcation Stents: Biosensors Program Update

Dedicated Bifurcation Stents: STENTYS Program Update

Strong Showing for Bioabsorbable-Scaffold DES

One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY™ Stent Versus PROMUS Element™ Platinum Chromium Stent

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

Extent, Characterization, and Clinical Implications of Untreated Lesions with High Plaque Burden after Successful Percutaneous Coronary Intervention: A PROSPECT Substudy.

Elixir Medical Announces DESolve Nx International Pivotal Trial Initiation for Fully Bioresorbable Coronary Scaffold System

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

Elixir Medical Corporation Announces Successful Completion of First-In-Man Study Enrollment for Fully Bioresorbable Drug Eluting Coronary Scaffold System

Axxess™ Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Three Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content